Sigachi Industries Limited has received the Terms of Reference (ToR) from the State Environment Impact Assessment Authority (SEIAA) of Andhra Pradesh for its planned manufacturing facility at Orvakal in Kurnool district. The proposed unit will focus on the production of bulk drugs, drug intermediates, and specialty chemicals.
The facility is planned over 25.09 acres at Plot No. A-10, located in the Guttapadu-Orvakal Node. It falls under Category B1 as per the Environmental Impact Assessment (EIA) Notification of 2006, specifically under Schedule 5(f), which covers synthetic organic chemicals projects.
With the ToR in place, the company is set to begin the Environmental Clearance (EC) process on 15 July 2025. Project development activities are scheduled to start from 1 August 2025. The upcoming facility is expected to support the company’s capacity for manufacturing active pharmaceutical ingredients and broaden its operational base to serve both regulated and semi-regulated markets.
Amit Raj Sinha, Managing Director and CEO of Sigachi Industries Limited, stated, “This is a significant milestone in our journey to become a vertically integrated pharmaceutical manufacturing company. The Orvakal project will anchor our next phase of growth in APIs and specialty chemicals, helping us create scalable, sustainable, and compliant operations for global markets.
At Sigachi, we are strategically positioning ourselves to cater to increasing global demand by building capacity closer to key markets and regulatory jurisdictions. The new facility will not only strengthen our product supply chain but also enable faster commercialization, seamless tech transfers, and enhanced responsiveness to evolving customer requirements.”
